BTK inhibitors
The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula (I), or pharmaceutically acceptable salts or stereoisomers thereof, or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of Btk inhibitor compounds of Formula (I) in the treatment of Btk mediated disorders.
MERCK SHARP & DOHME CORP.
A A A A A A A A A A A A A C C A A
A61K A61K A61K A61K A61P A61K A61P A61P A61P A61P A61K A61P A61P C07D C07K A61P A61P
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional additional inventional inventional inventional inventional inventional inventional
Jian Shilan Joseph A. Deodial Guy Hao Wensheng Younong Chundao Abdul-Basit Rajan Sobhana Babu
Liu Liu Kozlowski Guiadeen Wu Yu Yu Yang Alhassan Anand Boga